On 22 and 23 June 2023, EPHA attended the kick-off workshop of the multistakeholder platform for the Accelerating Clinical Trials in the EU (ACT EU) initiative organized by the European Medicines Agency. EPHA also contributed to a session aimed at discussing “how to...
With International Romani Day on 8 April, and Roma Week from 24 to 27 April, April was truly in the spirit of Roma equality. Like in previous years, these events allow civil society and policy makers alike to discuss the way forward for Roma equality. This year’s Roma...
Guest article by Norbert Couespel, Policy and Research Officer at European Cancer Organisation During the European Cancer Summit held on 16 and 17 November 2022, the European Cancer Organisation launched the European Cancer Pulse, a new data visualisation tool...
While the COVID-19 pandemic has brought access and affordability of medicines to the spotlight, it has also underscored the need for more balance, transparency, and accountability in the pharmaceutical sector. The 2022 Access to Medicines Forum coincides with the...
More than 32 million adults and 170,000 children live with a form of diabetes in the EU. Although 14 types of diabetes have been identified so far, the most common are Type 1 and Type 2. Most cases of Type 2 Diabetes are preventable. Yet, Type 1 and other forms are...
By Polina Starchenko, European Respiratory Society To mark the European Antibiotic Awareness Week, the European Respiratory Society and VALUE-Dx project team hosted an online event: “Rapid diagnostics to revolutionise our response to respiratory infections: Fighting...
